Grantclosed🌐 United StatesRFA-FD-22-001

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required

Food and Drug Administration

Details?

Posted: Feb 17, 2021
Response deadline: Mar 11, 2024, 12:00 AM UTC
Type: Grant
Category: 93.103
Status: closed
Buyer: Food and Drug Administration
Department: HHS-FDA
Jurisdiction: United States
Reference #: RFA-FD-22-001

Doc Type: synopsis

Similar past solicitations

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
United States · Aug 23, 2024
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
United States · Jan 8, 2025
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
United States · Jan 13, 2025
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
United States · Nov 21, 2024
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
United States · Jun 5, 2025
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
United States · Feb 2, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.